Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 93 of 93 entries
View as:

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Phase: N/A Priority: Normal
NCT ID: NCT00120783 Org: User:
Start: 02/28/02 End: 08/31/03 Due: 08/31/04

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Phase: N/A Priority: Normal
NCT ID: NCT00640887 Org: User:
Start: 02/28/09 End: 10/31/10 Due: 10/31/11

Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis

Phase: N/A Priority: Normal
NCT ID: NCT00536627 Org: User:
Start: 01/31/08 End: 11/30/10 Due: 11/30/11

Immunology of the Infection Perinatal

Phase: N/A Priority: Normal
NCT ID: NCT01055873 Org: User:
Start: 02/28/07 End: 02/28/09 Due: 02/28/10

Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)

Phase: N/A Priority: Normal
NCT ID: NCT00158457 Org: User:
Start: 06/30/04 End: 12/31/06 Due: 12/31/07

AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00121758 Org: User:
Start: 09/30/04 End: 12/31/07 Due: 12/31/08

Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

Phase: N/A Priority: Normal
NCT ID: NCT00148824 Org: User:
Start: 02/28/03 End: 01/31/06 Due: 01/31/07

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT00432419 Org: User:
Start: 02/28/07 End: 10/31/08 Due: 10/31/09

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00823342 Org: User:
Start: 12/14/08 End: 12/14/08 Due: 12/14/09

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00127569 Org: User:
Start: 05/31/03 End: 01/31/06 Due: 01/31/07

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Phase: N/A Priority: Normal
NCT ID: NCT00454337 Org: User:
Start: 05/31/07 End: 09/30/08 Due: 09/30/09

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Phase: N/A Priority: Normal
NCT ID: NCT00158470 Org: User:
Start: 09/30/03 End: 05/31/07 Due: 05/31/08

Cohort of Young Adults Infected With HIV Since Birth or During Childhood

Phase: N/A Priority: Normal
NCT ID: NCT01269632 Org: User:
Start: 06/30/10 End: 12/27/18 Due: 12/27/19

Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT00196664 Org: User:
Start: 10/31/05 End: 02/28/09 Due: 02/28/10

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Phase: N/A Priority: Normal
NCT ID: NCT00196625 Org: User:
Start: 11/30/00 End: 02/28/02 Due: 02/28/03

Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention

Phase: N/A Priority: Normal
NCT ID: NCT03235310 Org: User:
Start: 07/31/97 End: 03/31/23 Due: 03/31/24

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

Phase: N/A Priority: Normal
NCT ID: NCT00383734 Org: User:
Start: 12/31/06 End: 09/30/10 Due: 09/30/11

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Phase: N/A Priority: Normal
NCT ID: NCT00122603 Org: User:
Start: 12/31/05 End: 08/31/07 Due: 08/31/08